Slide 1: Presentation of Company Activities (ASX cover letter)
BIOTEC OT timitea A.BN, 60 086 399 144 Level 8, 261 George Street Sydney NSW 2000 Tel: (61-2) 9247 8212 Fax: (61-2) 9247 3932 E-mail: pnightingale@biotron.com.au Website: www.biotron.com.au 27 June 2006 The Manager Companies Australian Stock Exchange Limited 20 Bridge Street Sydney NSW 2000 (21 page
Slide 2: Biotron - Dr. Michelle Miller, June 2006
Biotrtron Dr. Michelle Miller June 2006
Slide 3: Lo va) a a _ Te / ie . WOUSEREEL ye ay a ne
Lo va) a a _ Te / ie . WOUSEREEL ye ay a ne aE aS ae ue oUF _ 7 _ y, a a ye Le - We ea
Slide 4: LLL
q De, oe LLL Lo _ Biotroa Lim oy Oe a 7 ted
Slide 5: —. oo oe oo —— — oe — oo and in NCW way Us
—. oo oe oo —— — oe — oo and 8 in NCW way Us at attack the v a (30) me oO = a : E os oO 3 (og = S eg ‘eas E No) = oO (a 2 oS io) 2 co S oO : (= = th * Pherapy ly Active Anti Retroviral | High! XK
Slide 6: J é oo — OO | Le To Li — ad compound to o
J é oo — OO | Le To Li — ad compound to o le as > oto 2 val | NIC ; — — — ~— Po | ate 2005 selected BIT225 take to the cl In |
Slide 7: : Ay ey
q es : Ay ey a y 7) Lo Lay ee is a — Ly J : j J a eT Z 7) us Lig y J Ly Lo 7 ee a Ty, y q ap Le PO De ie IRE ECHO es eae Te LET TOS Te ns y Ly 7 a a de a Le Uy oe i ~~ CrC— ‘$CUUUCC™CcCc cll y ae ay ye ay) ae ee Loe eae LD oo / : | 7 L | / : 7 ; CC oe oo Lo 7 Pe ue : es q a ted _ Biotroa Lim
Slide 8: Assembly and budding
Assembly & bugding Penetration gpi20 BIT compounds interrupt budding process Attachment
Slide 9: Biotron's HIV Drug in Action
BIOTRON’S HIV DRUG IN ACTION Healthy -.__ Damaged, non- infectious HIV | infectious HIV HIV inside untreated human HIV inside human cells treated cells with BIT-225
Slide 10: Leu
j — eo Leu To — ir cells oo — l reservo Ifa ~ eo SL = S — ~~ S = ~~ 2 op = = go) = = Sn i) 5 2 HR Ss — oe the v eyles move uul oO TeServoirs tissues in surrounding ction fe the blood stream (0 set up in HIV-infected se of
Slide 11: a ee — ; ee i To Li oo eS SS OO eo Soe
a ee — ; ee i To Li 100 oo eS SS OO eo Soe . sm of act — saul — GS new mecha oO ca 2 FS ge e ao o = gc is 2 imp Simple chem Novel compound
Slide 12: a ee LD
a 7 7 2 ee 7 7 LD Loe Hes a ee uy ea Le ey, z 7 ey) ee ee ee ve Le j Ly y Ly Lo Lo a : ee ; oe ~ - Q oo ] A 7) Lo Le ee LD y Le. D) a a rr
Slide 13: imi
d Pr Fo | Le imi . Ic d tox | ee Ive an ot 5) ao oO = Cael 1CS * eo Oe therap isting ISL * Ex
Slide 14: LLL
d ee re i 5 LLL i ig) i iropo 7 ira lled v . — -— proteins ca oe Go o oe. oe. SS ed O E oS DM Coe oo : — er ee —
Slide 15: > = — — - g ca Le Te _ ee Le yy ee
> = — — - g ca Le Te 7 _ ee Le yy ee a S _. a aT. Cae a Eas 2 7 y Ios Woe ee Le Diy: ‘ey - — ay a a ay Le Uo —_ ua, _ Biotroa Lim ted
Slide 16: y a a : | a DU y d
a L ; 4 y a a : | a DU y d Lo ye oe ; ee y Co De : y de oF Le a Ly Cl — — De i 1 ee : o, : ‘— Be Ly, Vee ae fee 8 POs Ly CO a ™~ OO Ue L ee E u ; zy, | LL i Ll 7, oy oF Le Bee Se ee Rees ee Pe: eG. aE re TIS se es . iy ee ee i _ Uo oo | e eo ted _ Biotroa Lim
Slide 17: SOE
4 SOE 7) Cae UNE ey oe oy Ly oe ie yuu i yy 7 7. LD Le fe gy oy ea — — — 7 | Ly Co i Lo a LC _ Biotroa Lim ie ee ay ys ee 4 — ted i
Slide 18: es wif
a LD a ey 7 De es wif 4 ay Be G Ve 7a 1) C.7 Vi, i ane i~ L Pes we IE We y, . a _ ey Cee ye a [. By ’ oye , ye LO Ga ; “a | CaAlatk Dia _ Biotroa Lim Ty SSK L0 oy _ ted
Slide 19: A Geos
q A Geos aN i _ Le ; ye 2 7 Gy, Oe 7 Z ye TD y 2 Ly fe oe , ges J Ly) a ‘ Co ay ted _ Biotroa Lim
Slide 20: Loe
Loe ae es 7 Lo Cy ‘ ™ Vin. a yy ) ie Dy i y y Ae ae ie a i LE a yy Ue i oe 7 ; ) y o 2 es 7 ey Gage) Se Ge y y a Q a Lye Bee J Wee | y 8 WOE _ a i Z _ We yy LIE My LLL De Sie ISITE SE AD EBD ESS OR : oe y y 7 L ae Le ie yy 5 Le ted _ Biotroa Lim
Slide 21: Dr Michelle Miller
Dr Michelle Miller Chief Executive Officer 02 6125 8001 mmiller@biotron.com.au www.biotron.com.au